India  

Drugs Controller General of India

Director of CDSCO

Drugs Controller General of India    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Drugs Controller General of India: Director of CDSCO
Drugs Controller General of India (DCGI) is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India. Drugs Controller General of India, comes under the Ministry of Health & Family Welfare. DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India.

0
shares
ShareTweetSavePostSend
 

You Might Like


DCGI suspends ENTOD's PresVu eye drops licence after misleading marketing claims, company to challenge order in court

The drug regulator said the company made claims for the drug product for which it had not obtained approval from the Central Licensing Authority, thereby violating provisions under the New Drugs and..
DNA - Published

DCGI bans all charges, except supply, processing costs on blood units

The Drugs Controller General of India (DCI) on Thursday banned all charges except supply and processing costs on blood units.
DNA - Published

Blood not for sale, charge processing cost only, DCGI tells blood banks

DCGI has also asked the drug controller cum licensing authorities to direct all blood centres to adhere to the revised guidelines for recovery of processing charges. When a person donates blood, it is..
IndiaTimes - Published

Rule regulating Ayush ads set to go, but amendments to fill void in limbo for a year

The Drug Controller General of India (DCGI) has suggested that a rule regulating the advertisement of ayush drugs should only be withdrawn after amendments to the Drugs and Magic Remedies Act are..
IndiaTimes - Published

DCGI: In case of adverse reaction, don't use Digene gel

The Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digene gel - a commonly prescribed anti-acidity..
IndiaTimes - Published

Antacid Digene Gel recalled by Abbott, DCGI issues alert against household medication; know why

Digene Gel, which is used as an antacid in many Indian homes, is now under the radar of the DGCI as an alert has been issued after the product's recall.
DNA - Published

Mandatory testing of cough syrup before exports, DCGI asks labs to give top priority to such samples

Cough syrup exporters will have to produce a certificate of analysis issued by a government laboratory before the product is exported, effective June 1, the Directorate General of Foreign Trade (DGFT)..
IndiaTimes - Published

Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..
IndiaTimes - Published

Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults

DCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.
DNA - Published